Risk of kidney dysfunction in NAFLD.
The timely identification of traditional and non-traditional precursors and risk factors for chronic kidney disease (CKD) (a systemic and frequent disease defined as a decreased kidney function documented by reduced glomerular filtration rate, or markers of kidney damage, or both) is relevant in clinical practice, as CKD increases the risk of developing end-stage renal disease and other serious comorbidities. A possible relationship between non-alcoholic fatty liver disease (NAFLD) (which is the most common chronic disease in many developed and developing countries) and CKD has obtained recent scientific interest. A systematic literature search using appropriate keywords was made to identify articles investigating the association between NAFLD and CKD. Several observational studies and meta-analyses have reported the existence of an independent association between NAFLD and risk of CKD in patients with and without diabetes. However, while the association between NAFLD and CKD is strong across various patient populations, whether NAFLD is independently associated to the development and progression of CKD is still debatable. Emerging evidence also suggests a potential association between patatin-like phospholipase domain-containing protein-3 (PNPLA3) rs738409 genotype (the most important genetic variant associated with NAFLD) and decreasing kidney function, independent of NAFLD. Convincing evidence now indicates that CKD is increased among patients with NAFLD. For this reason, patients with NAFLD should be regularly monitored for renal function and, on the other side, NAFLD should be considered in all patients with CKD, especially if they are obese or have diabetes.